Recent Updates
Recently added Catalysts
AGEN

Agenus to Present at the 31st Annual Cowen and Company Health Care Conference

Key Takeaway: Agenus Inc. (Nasdaq:AGEN) announced today that Agenus management will present a corporate overview at the 31st Annual Cowen and Company Health Care Conference on Wednesday, March 9th at 8:45 am ET at the Boston Marriott Copley Place Hotel. The live and archived webcast of the co

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+52%
120-day peak, hindsight
Typical move
6.2%
average across 4 past catalysts
Cash runway
~1 mo
High dilution risk
Lead asset
Botensilimab
Phase 1 · Pancreatic Cancer Metastatic

Full Press Release Details

Agenus Inc. (Nasdaq:AGEN) announced today that Agenus management will present a corporate overview at the 31st Annual Cowen and Company Health Care Conference on Wednesday, March 9th at 8:45 am ET at the Boston Marriott Copley Place Hotel.
The live and archived webcast of the company presentation will be accessible from the company's website at www.agenusbio.com/webcast. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Agenus website for one month following the conference.
Agenus Inc. (formerly Antigenics Inc.) is a biotechnology company working to develop treatments for cancers and infectious diseases. For more information, please visit www.agenusbio.com.
Last updated: Mar 2, 2011